Langham Ronald Leroy JR
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Langham Ronald Leroy JR. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| EHAB | EVP Clinical Excel. & Strategy | Award / Grant | 7,092 | $8.02 | $56,878 | Mar 6, 2025 |
| EHAB | EVP Clinical Excel. & Strategy | Tax Withholding | 3,041 | $8.37 | $25,453 | Mar 1, 2025 |
| EHAB | EVP Clinical Excel. & Strategy | Tax Withholding | 334 | $8.26 | $2,759 | Feb 25, 2025 |
| EHAB | EVP Clinical Excel. & Strategy | Tax Withholding | 656 | $7.81 | $5,123 | Jan 1, 2025 |
| EHAB | EVP Clinical Excel. & Strategy | Tax Withholding | 673 | $8.75 | $5,889 | Jul 1, 2024 |
| EHAB | EVP Clinical Excel. & Strategy | Sale | 634 | $8.81 | $5,586 | Mar 1, 2024 |
| EHAB | EVP Clinical Excel. & Strategy | Tax Withholding | 181 | $9.49 | $1,718 | Feb 25, 2024 |
| EHAB | EVP Clinical Excel. & Strategy | Tax Withholding | 1,043 | $10.35 | $10,795 | Jan 1, 2024 |
| EHAB | EVP Clinical Excel. & Strategy | Purchase | 10,000 | $11.99 | $119,900 | May 18, 2023 |
| EHAB | EVP Clinical Excel. & Strategy | Award / Grant | 2,390 | — | — | Mar 1, 2023 |
| EHAB | EVP Clinical Excel. & Strategy | Award / Grant | 1,594 | — | — | Mar 1, 2023 |